SG11201607035YA - Methods and compositions for personalized pain management - Google Patents

Methods and compositions for personalized pain management

Info

Publication number
SG11201607035YA
SG11201607035YA SG11201607035YA SG11201607035YA SG11201607035YA SG 11201607035Y A SG11201607035Y A SG 11201607035YA SG 11201607035Y A SG11201607035Y A SG 11201607035YA SG 11201607035Y A SG11201607035Y A SG 11201607035YA SG 11201607035Y A SG11201607035Y A SG 11201607035YA
Authority
SG
Singapore
Prior art keywords
compositions
methods
pain management
personalized pain
personalized
Prior art date
Application number
SG11201607035YA
Other languages
English (en)
Inventor
Senthilkumar Sadhasivam
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Publication of SG11201607035YA publication Critical patent/SG11201607035YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
SG11201607035YA 2014-02-24 2015-02-23 Methods and compositions for personalized pain management SG11201607035YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461943944P 2014-02-24 2014-02-24
PCT/US2015/017134 WO2015127379A1 (en) 2014-02-24 2015-02-23 Methods and compositions for personalized pain management

Publications (1)

Publication Number Publication Date
SG11201607035YA true SG11201607035YA (en) 2016-09-29

Family

ID=52597325

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201607035YA SG11201607035YA (en) 2014-02-24 2015-02-23 Methods and compositions for personalized pain management

Country Status (10)

Country Link
US (1) US10878939B2 (ko)
EP (1) EP3110968B1 (ko)
JP (1) JP6581117B2 (ko)
KR (1) KR20160123385A (ko)
CN (1) CN106460042A (ko)
AU (1) AU2015218692A1 (ko)
CA (1) CA2940422A1 (ko)
IL (1) IL247389A0 (ko)
SG (1) SG11201607035YA (ko)
WO (1) WO2015127379A1 (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8930178B2 (en) 2007-01-04 2015-01-06 Children's Hospital Medical Center Processing text with domain-specific spreading activation methods
WO2013082308A1 (en) 2011-11-30 2013-06-06 Children's Hospital Medical Center Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
WO2015127379A1 (en) 2014-02-24 2015-08-27 Children's Hospital Medical Center Methods and compositions for personalized pain management
WO2016023026A1 (en) 2014-08-08 2016-02-11 Children's Hospital Medical Center Diagnostic method for distinguishing forms of esophageal eosinophilia
JP6702686B2 (ja) * 2015-10-09 2020-06-03 株式会社エムティーアイ 表現型推定システム及び表現型推定プログラム
US10821094B2 (en) 2016-01-13 2020-11-03 Children's Hospital Medical Center Compositions and methods for treating allergic inflammatory conditions
EP3544611A4 (en) * 2016-11-23 2020-09-09 Assurex Health, Inc. METHODS FOR TREATMENT OF OPIOID DEPENDENCE
US11618924B2 (en) 2017-01-20 2023-04-04 Children's Hospital Medical Center Methods and compositions relating to OPRM1 DNA methylation for personalized pain management
CN113570064A (zh) * 2017-05-05 2021-10-29 第四范式(北京)技术有限公司 利用复合机器学习模型来执行预测的方法及系统
US11859250B1 (en) 2018-02-23 2024-01-02 Children's Hospital Medical Center Methods for treating eosinophilic esophagitis
JP7078458B2 (ja) * 2018-05-30 2022-05-31 株式会社Soken 操舵角決定装置、および、自動運転車
CN108929913A (zh) * 2018-08-21 2018-12-04 潍坊德诺泰克生物科技有限公司 用于检测rs2032582的引物探针组及其应用
AU2019370896A1 (en) * 2018-10-31 2021-06-17 Ancestry.Com Dna, Llc Estimation of phenotypes using DNA, pedigree, and historical data
CN109741826B (zh) * 2018-12-13 2022-09-13 华中科技大学鄂州工业技术研究院 麻醉评估决策树构建方法及设备
US20200211688A1 (en) * 2018-12-28 2020-07-02 Xing-Liang Liu Method and system for providing a personalized cannabinoid treatment regimen
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
CN111312387A (zh) * 2020-01-16 2020-06-19 安徽医科大学第一附属医院 一种男性慢性前列腺炎/慢性盆腔痛综合征疼痛严重程度预测模型及其建立
WO2021262871A1 (en) * 2020-06-25 2021-12-30 Greenway Dna Inc. Methods and systems for providing a personalized treatment regimen using cannabinoid or psychedelic compounds
CN115976190A (zh) * 2022-11-15 2023-04-18 苏州吉赛基因测序科技有限公司 剖宫产患者术后镇痛用药相关基因分型检测的产品及用途

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5976081A (en) 1983-08-11 1999-11-02 Silverman; Stephen E. Method for detecting suicidal predisposition
US4675904A (en) 1983-08-11 1987-06-23 Compusonics, Inc. Method for detecting suicidal predisposition
US5148483A (en) 1983-08-11 1992-09-15 Silverman Stephen E Method for detecting suicidal predisposition
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US6287850B1 (en) 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
DE69527585T2 (de) 1994-06-08 2003-04-03 Affymetrix Inc Verfahren und Vorrichtung zum Verpacken von Chips
US6300063B1 (en) 1995-11-29 2001-10-09 Affymetrix, Inc. Polymorphism detection
EP2369007B1 (en) 1996-05-29 2015-07-29 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US6429027B1 (en) 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US8301468B2 (en) 2000-05-15 2012-10-30 Optuminsight, Inc. System and method of drug disease matching
EP1816214B1 (en) 2000-07-11 2008-06-25 Kirk Hogan Methods and compositions for perioperative genomic profiling
US7062443B2 (en) 2000-08-22 2006-06-13 Silverman Stephen E Methods and apparatus for evaluating near-term suicidal risk using vocal parameters
US7139699B2 (en) 2000-10-06 2006-11-21 Silverman Stephen E Method for analysis of vocal jitter for near-term suicidal risk assessment
US20030092019A1 (en) 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
AU2002366713A1 (en) 2001-12-20 2003-07-09 Incyte Genomics, Inc. Nucleotide polymorphisms associated with osteoarthritis
US7716207B2 (en) 2002-02-26 2010-05-11 Odom Paul S Search engine methods and systems for displaying relevant topics
WO2005105093A2 (en) 2003-08-26 2005-11-10 Duke University METHOD OF ARRESTING THE SIDE EFFECTS OF µ-OPIOID RECEPTOR AGONISTS DURING THEIR ADMINISTRATION
EP2078749A1 (en) 2004-03-31 2009-07-15 Tokyo Metropolitan Organization for Medical Research Method of evaluating drug sensitivity by analyzing the mu-opioid receptor gene
WO2006119343A1 (en) 2005-05-03 2006-11-09 Children's Hospital Medical Center Determination of eosinophilic esophagitis
WO2007070252A2 (en) * 2005-11-30 2007-06-21 The University Of North Carolina At Chapel Hill Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same
US7754428B2 (en) 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
JP5308644B2 (ja) 2006-08-31 2013-10-09 公益財団法人東京都医学総合研究所 Girkチャネル遺伝子解析による薬物感受性の評価方法
US7899764B2 (en) 2007-02-16 2011-03-01 Siemens Aktiengesellschaft Medical ontologies for machine learning and decision support
US20100240552A1 (en) 2007-04-25 2010-09-23 Tokyo Metropolitan Organization For Medical Research Method for evaluation of drug sensitivity by analysis of pomc gene
WO2009067473A2 (en) 2007-11-20 2009-05-28 Wisconsin Alumni Research Foundation Method of improving palliative care
US8249225B2 (en) 2008-03-14 2012-08-21 International Business Machines Corporation Identifying caller preferences based on voice print analysis
EP2367951B1 (en) 2008-11-26 2014-06-11 Merck Serono S.A. Compositions and methods for treating growth hormone deficiency
WO2010065916A1 (en) 2008-12-04 2010-06-10 Rush University Medical Center Dna methylation based test for monitoring efficacy of treatment
WO2010126867A1 (en) 2009-04-27 2010-11-04 Cincinnati Children's Hospital Medical Center Computer implemented system and method for assessing a neuropsychiatric condition of a human subject
GB2483108A (en) 2010-08-27 2012-02-29 Walid Juffali Monitoring neurological electrical signals to detect the onset of a neurological episode
JP6053267B2 (ja) 2010-09-03 2016-12-27 公益財団法人東京都医学総合研究所 アドレナリン受容体遺伝子解析による薬物感受性および疾患脆弱性の評価方法
US8694335B2 (en) 2011-02-18 2014-04-08 Nuance Communications, Inc. Methods and apparatus for applying user corrections to medical fact extraction
EP2723899B1 (en) 2011-06-21 2020-11-18 Children's Hospital Medical Center Diagnostic methods for eosinophilic esophagitis
WO2013082308A1 (en) 2011-11-30 2013-06-06 Children's Hospital Medical Center Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
EP2817417B1 (en) 2012-02-24 2017-10-25 Children's Hospital Medical Center Esophageal microrna expression profiles in eosinophilic esophagitis
WO2013155010A1 (en) 2012-04-09 2013-10-17 Children's Hospital Medical Center Non-invasive biomarkers for eosinophilic esophagitis
US8377657B1 (en) 2012-05-15 2013-02-19 Predictive Biosciences Corporation Primers for analyzing methylated sequences and methods of use thereof
US10132809B2 (en) 2012-10-10 2018-11-20 Rhote Island Hospital Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis
US9691411B2 (en) 2013-05-24 2017-06-27 Children's Hospital Medical Center System and method for assessing suicide risk of a patient based upon non-verbal characteristics of voice data
US20160180041A1 (en) 2013-08-01 2016-06-23 Children's Hospital Medical Center Identification of Surgery Candidates Using Natural Language Processing
WO2015127379A1 (en) 2014-02-24 2015-08-27 Children's Hospital Medical Center Methods and compositions for personalized pain management
WO2016023026A1 (en) 2014-08-08 2016-02-11 Children's Hospital Medical Center Diagnostic method for distinguishing forms of esophageal eosinophilia
US11618924B2 (en) 2017-01-20 2023-04-04 Children's Hospital Medical Center Methods and compositions relating to OPRM1 DNA methylation for personalized pain management
US20210205346A1 (en) 2018-06-28 2021-07-08 Children's Hospital Medical Center Methods and compositions relating to personalized pain management

Also Published As

Publication number Publication date
EP3110968A1 (en) 2017-01-04
US10878939B2 (en) 2020-12-29
JP2017512069A (ja) 2017-05-18
JP6581117B2 (ja) 2019-09-25
CA2940422A1 (en) 2015-08-27
US20170061073A1 (en) 2017-03-02
EP3110968B1 (en) 2019-04-17
KR20160123385A (ko) 2016-10-25
CN106460042A (zh) 2017-02-22
IL247389A0 (en) 2016-11-30
AU2015218692A1 (en) 2016-09-15
WO2015127379A1 (en) 2015-08-27

Similar Documents

Publication Publication Date Title
IL247389A0 (en) Methods and preparations for personal pain management
HK1257295A1 (zh) 用於免疫腫瘤學的組合物和方法
ZA201804070B (en) Eif4-a-inhibiting compounds and methods related thereto
IL250998A0 (en) Microbial compositions and methods
GB2535253B (en) Compositions and methods
FI3215147T3 (fi) Hermostoa salpaavia norketamiiniyhdisteitä ja -menetelmiä
PL3104718T3 (pl) Kompozycja żelowa zawierająca tytoń
ZA201608046B (en) Pesticidal compositions and related methods
GB201411197D0 (en) Composition and use thereof
HUE055473T2 (hu) Difluormetil-aminopiridinek és difluormetil-aminopirimidinek
PT3015526T (pt) Composição à base de hidrofluoroolefina e sua utilização
EP3114313A4 (en) Inversion techniques for real-time well placement and reservoir characterization
GB201417828D0 (en) New methods and compositions
IL246879A0 (en) Preparations of Epilimod and methods of using them
HK1217142A1 (zh) 種用戶群的創建方法和設備
SG11201704473WA (en) New methods and uses
GB201420140D0 (en) Mobility management
ZA201703398B (en) Pharmaceutical composition and methods
HK1243342A1 (zh) 化合物和方法
GB201411196D0 (en) Composition and use thereof
HK1220676A1 (zh) 配置件和方法
GB201402915D0 (en) Compositions and methods
GB201421947D0 (en) Elecroplating method and composition
GB201511410D0 (en) Pain supressars
GB201419559D0 (en) Therapeutic compositions and methods